Insider Transactions in Q4 2025 at Relmada Therapeutics, Inc. (RLMD)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
11,665
+1.44%
|
$46,660
$4.12 P/Share
|
|
Dec 15
2025
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,500
+2.07%
|
$110,000
$4.12 P/Share
|
|
Nov 05
2025
|
Paul Edward Kelly COO |
BUY
Open market or private purchase
|
Direct |
90,000
+15.2%
|
$180,000
$2.2 P/Share
|
|
Nov 05
2025
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
272,500
+17.64%
|
$545,000
$2.2 P/Share
|
|
Nov 05
2025
|
Chuck Ence CA and CO |
BUY
Open market or private purchase
|
Direct |
136,000
+25.19%
|
$272,000
$2.2 P/Share
|
|
Nov 05
2025
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500,000
+38.81%
|
$1,000,000
$2.2 P/Share
|